30.91 USD
-0.3 (-0.96%)
30.91 USD
0 (0%)
ChartMill assigns a Buy % Consensus number of 85% to STOK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 31.51. This target is 1.93% above the current price.
STOK was analyzed by 17 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about STOK.
In the previous month the buy percentage consensus was at a similar level.
STOK was analyzed by 17 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-11-05 | BTIG | Reiterate | Buy -> Buy |
| 2025-11-05 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-11-05 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-11-03 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-13 | BTIG | Maintains | Buy -> Buy |
| 2025-10-10 | Needham | Maintains | Buy -> Buy |
| 2025-08-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-13 | Wedbush | Maintains | Outperform -> Outperform |
| 2025-07-18 | Jefferies | Initiate | Buy |
| 2025-07-01 | Needham | Reiterate | Buy -> Buy |
| 2025-05-14 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-04-09 | Needham | Reiterate | Buy -> Buy |
| 2025-03-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-18 | Needham | Reiterate | Buy -> Buy |
| 2025-02-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-18 | Needham | Reiterate | Buy -> Buy |
| 2025-02-18 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-08 | Needham | Maintains | Buy -> Buy |
| 2025-01-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-12-20 | Chardan Capital | Initiate | Buy |
| 2024-12-10 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2024-11-06 | Needham | Reiterate | Buy -> Buy |
| 2024-11-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-09-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-08-08 | Needham | Reiterate | Buy -> Buy |
| 2024-07-11 | Wedbush | Reiterate | Outperform -> Outperform |
| 2024-06-28 | Needham | Reiterate | Buy -> Buy |
| 2024-05-07 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-05-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
STOKE THERAPEUTICS INC / STOK FAQ
Can you provide the average price target for STOKE THERAPEUTICS INC stock?
17 analysts have analysed STOK and the average price target is 31.51 USD. This implies a price increase of 1.93% is expected in the next year compared to the current price of 30.91.
What is the consensus rating for STOK stock?
The consensus rating for STOKE THERAPEUTICS INC (STOK) is 84.7059 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts have analysed STOKE THERAPEUTICS INC (STOK)?
The number of analysts covering STOKE THERAPEUTICS INC (STOK) is 17.